Lots of people are talking about the first-in-class PH drug sotatercept, which has recently been approved for use in America. Here, PHA UK Chair Dr Iain Armstrong explains what happens next - and what will be considered when it comes to making decisions for the UK...
30 July 2024
Following a rigorous assessment, our information resources have been re-certified with a Patient Information Forum (PIF) quality mark for the fourth year running.
19 July 2024
Best practice was shared, and valuable connections were formed, at the inspiring World Symposia on Pulmonary Hypertension.
4 July 2024
Rashida Begum on dealing with her diagnosis, and why she now celebrates every little thing...
24 June 2024
Our response to proposed reforms to the disability-benefits system.
1 May 2024
‘PHoenix’ is an innovative new trial testing how well PAH drugs can be personalised for patients – and it’s set to roll out across more of the UK’s specialist centres soon. We spoke to Dr Frankie Varian of the Sheffield Pulmonary Vascular Disease Unit to find out more about the study’s aims, and how it’s been shaped by patients from the start…
18 April 2024
